The use of rice seeds to produce human pharmaceuticals for oral therapy.
about
The dynamic behavior of storage organelles in developing cereal seeds and its impact on the production of recombinant proteinsProduction of Biologically Active Cecropin A Peptide in Rice Seed Oil BodiesMolecular farming on rescue of pharma industry for next generations.Characterization of wastewater treatment plant microbial communities and the effects of carbon sources on diversity in laboratory modelsConcentrated protein body product derived from rice endosperm as an oral tolerogen for allergen-specific immunotherapy--a new mucosal vaccine formulation against Japanese cedar pollen allergyProduction of phytotoxic cationic α-helical antimicrobial peptides in plant cells using inducible promoters.Transgenic rice seed expressing flavonoid biosynthetic genes accumulate glycosylated and/or acylated flavonoids in protein bodies.Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks.Rice seed for delivery of vaccines to gut mucosal immune tissues.Analysis of Recombinant Proteins in Transgenic Rice Seeds: Identity, Localization, Tolerance to Digestion, and Plant Stress Response.Editorial: from plant biotechnology to bio-based products.Efficient recovery of recombinant proteins from cereal endosperm is affected by interaction with endogenous storage proteins.Compensatory rebalancing of rice prolamins by production of recombinant prolamin/bioactive peptide fusion proteins within ER-derived protein bodies.Imaging the ER and Endomembrane System in Cereal Endosperm.Deposition mode of transforming growth factor-β expressed in transgenic rice seed.
P2860
Q26853066-92CC90D8-B9DC-4C16-BF97-5C345F58C913Q28552404-9A229849-5918-4DEE-BC0E-B529111F69A7Q30252148-C36F789B-C065-4880-8A88-6BEDDA9CD722Q34078829-399AAA98-3A25-4E1A-81FB-92190B88B588Q35182364-F74A3140-6C38-48D3-8A45-D1F235F3EBF4Q35410593-FD4ACED5-71D6-464A-A503-58FC613DC5EBQ36380084-0BBEFBFD-9C4A-4AF8-B7EF-ECB6279E5FDDQ38232409-DDE702AB-C416-470F-B4DB-02917274BF48Q38534952-F53FA3A8-5387-4443-982E-85E7BDE67FEBQ38937876-93176204-0D9F-47F5-93D5-5F1E613B4FE3Q44276704-D0F6AA7D-915A-4DEC-B235-7B7A6B9159D8Q44704323-B81FB8F6-C53B-4E7B-9106-2507B8F8BA55Q47597043-F496BC6A-431F-4321-98B0-4B441BB40E56Q47635576-5AE1F62E-6AAF-48C8-8F1A-F3E412C419CDQ51540310-2BEF43FF-5EB1-4166-8EDE-FD9DB18EE947
P2860
The use of rice seeds to produce human pharmaceuticals for oral therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The use of rice seeds to produce human pharmaceuticals for oral therapy.
@en
type
label
The use of rice seeds to produce human pharmaceuticals for oral therapy.
@en
prefLabel
The use of rice seeds to produce human pharmaceuticals for oral therapy.
@en
P2860
P356
P1476
The use of rice seeds to produce human pharmaceuticals for oral therapy.
@en
P2093
Fumio Takaiwa
P2860
P304
P356
10.1002/BIOT.201300065
P50
P577
2013-09-17T00:00:00Z